Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
However, in special circumstances such as weather conditions or other unforeseen delays, this timeframe may vary
Our Semaglutide Program Structure At Hawaii Wellness Clinic in , our Semaglutide program begins with a comprehensive medical consultation during which your physician reviews your health history, metabolic labs, weight loss history, and treatment goals
This includes managing chronic conditions like diabetes and obesity
Comprehensive List of FDA-approved GLP-1 Receptor Agonists (as of mid-2025)Jun 14, 20252 min read All Available GLP-1 Receptor AgonistsBrand NameGeneric NameManufacturerOzempicSemaglutideNovo NordiskWegovySemaglutide (higher dose)Novo NordiskRybelsusSemaglutide (oral)Novo NordiskMounjaroTirzepatide (dual GLP-1/GIP)Eli LillyZepboundTirzepatide (weight loss)Eli LillyVictozaLiraglutideNovo NordiskSaxendaLiraglutide (higher dose for weight loss)Novo NordiskByettaExenatideAstraZenecaBydureon BCiseExenatide ERAstraZenecaAdlyxinLixisenatideSanofiTrulicityDulaglutideEli LillyEperzan / Tanzeum (withdrawn but notable)AlbiglutideGSK (discontinued) GLP-1 Comparison ChartNameBenefitsSide EffectsStudy LinksSemaglutide (Ozempic, Wegovy, Rybelsus)- Significant weight loss (up to 15%) - Lowers A1C ~1.5% - Cardiovascular protection (Ozempic) - Once-weekly (injection) or daily (oral)- Nausea - Vomiting - Diarrhea - Constipation - Risk of pancreatitisSTEP Trials (Wegovy) SUSTAIN Trials (Ozempic)Tirzepatide (Mounjaro, Zepbound)- Weight loss up to 20% - Superior A1C reduction (~2%+) - Combines GLP-1 + GIP effects - Weekly injection- GI upset - Fatigue - Constipation - Gallbladder issues (rare)SURMOUNT Trials (Zepbound) SURPASS Trials (Mounjaro)Liraglutide (Victoza, Saxenda)- A1C reduction ~1-1.5% - Weight loss up to 8% - Cardiovascular benefit (Victoza) - Daily injection- Nausea - Headache - Injection site irritation - Possible pancreatitisLEADER Trial (Victoza) SCALE Trial (Saxenda)Exenatide (Byetta, Bydureon)- A1C reduction ~1% - Weight neutral or mild loss - Twice-daily or weekly injection- Nausea - Hypoglycemia (esp
At Klinic, we understand that every individuals weight loss journey is unique
However, the plausible actions of GLP-1RAs on several reward domains may require more nuanced interpretation
